Approval · Notice of Compliance 26914 · 2021
COMIRNATY: Notice of Compliance 26914
Issued September 16, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26914
- Date
- September 16, 2021
- Company
- Biontech Manufacturing GmbhMainz, Rheinland-Pfalz, Germany
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMIRNATY | 02509210 | Cancelled Post Market |
Medicinal ingredients
- TOZINAMERAN 30 MCG per DOSE